NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1962407601 MD, MBA
Verify on CMS → Simranjit Galhotra, MD, MBA
Pulmonary Disease Physician in Show Low, Arizona.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 263 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$22.57
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Simranjit Galhotra, MD, MBA filed 1,174 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in Show Low, Arizona, prescribing 48% generic.
- 1K
- Part D claims, 2023
- 48%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Simranjit Galhotra, MD, MBA's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,174 Top 23% higher than 77% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Simranjit Galhotra, MD, MBA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Simranjit Galhotra, MD, MBA?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
1,174 19% vs specialty avg
Specialty distribution in Arizona
How Pulmonary Disease Physician compares to other specialties among Arizona providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Simranjit Galhotra, MD, MBA appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD, MBA credentials at 5300 S SUTTER DR, Show Low, AZ, 85901, with a listed phone of (928) 532-2200. NPI 1962407601 was issued on 06/18/2005.
Medicare Part D records for calendar year 2023 show 1,174 prescription claims written by this provider, covering 263 Medicare beneficiaries and totaling roughly $601K in drug spend, split 52% brand-name and 48% generic by claim count.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1962407601 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD, MBA |
| Gender | Male |
| NPI Issued | 06/18/2005 |
Hospital and facility affiliations
Facilities where Simranjit Galhotra, MD, MBA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Simranjit Galhotra, MD, MBA is affiliated with 3 Medicare-billing facilities across 2 states.
Rocky Mountain Sleep Disorders Center Inc
Great Falls, MT
Summit Healthcare Association
Show Low, AZ
Summit Healthcare Medical Associates
Show Low, AZ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Simranjit Galhotra, MD, MBA. Source: openpaymentsdata.cms.gov.
Total received
$23
Largest payer
Electromed, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Simranjit Galhotra, MD, MBA - brand share 52.0%
Pulmonary Disease Physician average
52% brand-name claims vs 48% generic, on 1,174 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,174
Total Claims
$601K
Total Drug Cost
263
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,455
- Total Day Supply
- 72,793
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $584K
- Generic Drug Cost
- $17K
- Antibiotic Claims
- 21
Patient Demographics
- Average Patient Age
- 70.9 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 60% female / 40% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Simranjit Galhotra, MD, MBA prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
293 claims
- Trelegy Ellipta
Trelegy Ellipta
263 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
166 claims
- Fluticasone Propio… 86
Fluticasone Propionate
86 claims
- Breo Ellipta 59
Breo Ellipta
59 claims
- Advair Diskus 30
Advair Diskus
30 claims
- Symbicort 27
Symbicort
27 claims
- Fluticasone-Salmet… 26
Fluticasone-Salmeterol
26 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 293 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 263 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 166 |
| Fluticasone Propionate | 86 |
| Breo Ellipta Fluticasone/Vilanterol | 59 |
| Advair Diskus Fluticasone Propion/Salmeterol | 30 |
| Symbicort Budesonide/Formoterol Fumarate | 27 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 26 |
| Spiriva Handihaler Tiotropium Bromide | 22 |
| Ventolin Hfa Albuterol Sulfate | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Simranjit Galhotra, MD, MBA fits within the Pulmonary Disease Physician landscape nationally.
9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Simranjit Galhotra, MD, MBA's 1,174 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Galhotra.
Dr. Andre Abbate
M.D.
Mesa, AZ
Dr. Hesham Abdelrazek
MD
Phoenix, AZ
Dr. Fadi Adra
M.D.,
Tucson, AZ
Dr. Michelle Aerni
D.O.
Flagstaff, AZ
Dr. Wahaj Ahmed
MD
Gilbert, AZ
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Arizona medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Arizona
Frequently Asked Questions
What is Simranjit Galhotra, MD, MBA's specialty? ▼
Simranjit Galhotra, MD, MBA specializes in Pulmonary Disease Physician and practices in Show Low, Arizona. Credentials: MD, MBA.
How much does Simranjit Galhotra, MD, MBA prescribe under Medicare Part D? ▼
In 2023, Simranjit Galhotra, MD, MBA wrote 1,174 Medicare Part D claims totaling $601K in drug costs for 263 beneficiaries.
Where is Simranjit Galhotra, MD, MBA located? ▼
Simranjit Galhotra, MD, MBA is located at 5300 S SUTTER DR, Show Low, AZ, 85901. Phone: (928) 532-2200.
What is Simranjit Galhotra, MD, MBA's NPI number? ▼
Simranjit Galhotra, MD, MBA's National Provider Identifier (NPI) is 1962407601, issued on 06/18/2005.
Does Simranjit Galhotra, MD, MBA prescribe more brand-name or generic drugs? ▼
Simranjit Galhotra, MD, MBA's prescribing is 52% brand-name and 48% generic drugs by claim count, with $584K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Simranjit Galhotra, MD, MBA prescribe most often? ▼
Based on 2023 Medicare Part D data, Simranjit Galhotra, MD, MBA's most frequently prescribed drugs include Montelukast Sodium, Trelegy Ellipta, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Simranjit Galhotra, MD, MBA accept Medicare? ▼
Simranjit Galhotra, MD, MBA appears in CMS Medicare data with 1,174 Part D claims and 263 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Simranjit Galhotra, MD, MBA's credentials? ▼
Simranjit Galhotra, MD, MBA's NPI is 1962407601 with credentials MD, MBA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.